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Introduction: Striatal dopamine depletion disrupts basal ganglia function and causes
Parkinson’s disease (PD). The pathophysiology of the dopamine-dependent relationship
between basal ganglia signaling and motor control, however, is not fully understood. We
obtained simultaneous recordings of local field potentials (LFPs) from the subthalamic
nucleus (STN) and electromyograms (EMGs) in patients with PD to investigate the
impact of dopaminergic state and movement on long-range beta functional connectivity
between basal ganglia and lower motor neurons.
Methods: Eight PD patients were investigated 3 months after implantation of a deep
brain stimulation (DBS)-system capable of recording LFPs via chronically-implanted
leads (Medtronic, ACTIVA PC+Sr). We analyzed STN spectral power and its coherence
with EMG in the context of two different movement paradigms (tonic wrist extension vs.
alternating wrist extension and flexion) and the effect of levodopa (L-Dopa) intake using
an unbiased data-driven approach to determine regions of interest (ROI).
Results: Two ROIs capturing prominent coherence within a grand average coherogram
were identified. A trend of a dopamine effect was observed for the first ROI
(50–150 ms after movement start) with higher STN-EMG coherence in medicated
patients. Concerning the second ROI (300–500 ms after movement start), an interaction
effect of L-Dopa medication and movement task was observed with higher coherence
in the isometric contraction task compared to alternating movements in the medication
ON state, a pattern which was reversed in L-Dopa OFF.
Discussion: L-Dopa medication may normalize functional connectivity between remote
structures of the motor system with increased upper beta coherence reflecting a
physiological restriction of the amount of information conveyed between remote
structures. This may be necessary to maintain simple movements like isometric
contraction. Our study adds dynamic properties to the complex interplay between STN
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spectral beta power and the nucleus’ functional connectivity to remote structures of
the motor system as a function of movement and dopaminergic state. This may help
to identify markers of neuronal activity relevant for more individualized programming of
DBS therapy.
Keywords: Parkinson’s disease, subthalamic nucleus, deep brain stimulation, local field potentials,
dopamine, movement
INTRODUCTION
In vivo recordings of basal ganglia neuronal activity in
Parkinson’s disease (PD) patients have been facilitated by the
chronic implantation of stimulation electrodes for therapeutic
deep brain stimulation (DBS; Benabid et al., 1994). Local field
potential (LFP) recordings from the subthalamic nucleus (STN),
the most common DBS target for PD (Deuschl et al., 2006;
Weaver et al., 2009; Follett et al., 2010; Schuepbach et al., 2013),
have revealed abnormally synchronized oscillatory activity in
the beta band (about 13–30 Hz) to be an electrophysiological
hallmark of the Parkinsonian state (Brown et al., 2001; Brown,
2003; Kühn et al., 2006, 2009). STN beta activity is most
prominent in the resting state of PD patients (López-Azcárate
et al., 2010), is attenuated by voluntary movement (Cassidy et al.,
2002; Levy et al., 2002; Priori et al., 2002; Kühn et al., 2004; Alegre
et al., 2005, 2013; Doyle et al., 2005; Foffani et al., 2005; Hebb
et al., 2012; Joundi et al., 2012, 2013; Litvak et al., 2012), and
increases again when movement voluntarily ends (Kühn et al.,
2004; Alegre et al., 2013). It has been suggested that the encoding
of steady motor states might be a physiological role of beta
rhythms, which become pathologically exaggerated as a result
of striatal dopamine depletion, a pathophysiological hallmark
of PD (Engel and Fries, 2010; Brittain and Brown, 2014). This
mechanism is supported by several studies demonstrating that
oral levodopa (L-Dopa) intake in PD patients desynchronizes
STN beta band activity (Brown et al., 2001; Levy et al., 2002;
Priori et al., 2004; Alegre et al., 2005; Kühn et al., 2006;
Hirschmann et al., 2013). Beta desynchronization is moreover
correlated with improved bradykinesia scores (Kühn et al.,
2006, 2009; Weinberger et al., 2006; Androulidakis et al.,
2008; Ray et al., 2008). Because of the correlative nature of
these experiments, it remains an open question whether STN
beta rhythms cause bradykinesia (Jenkinson and Brown, 2011),
despite ample evidence that beta exaggerations represent a
valid electrophysiological marker of the Parkinsonian motor
OFF state. Studies which evaluated the effects of dopamine
and movement on functional beta oscillatory coupling of STN,
motor cortex, and muscle activity have delivered conflicting
results (Marsden et al., 2001; Salenius et al., 2002; Litvak et al.,
2012; Hirschmann et al., 2013), possibly due to differences
in recording and analyses techniques as well as movement
paradigms. Frequency-specific coding of STN-muscle coherence
was found in the beta band during isometric contractions
and in the 31–45 Hz band during phasic motor activity in
PD patients after L-Dopa intake (Marsden et al., 2001). In
contrast, Hirschmann et al. (2013) found reduced STN-muscle
beta band coherence during alternating forearm movements
compared to isometric contractions, which was independent
of L-Dopa medication. One study found STN-motor cortex
beta coherence in a task of tonic muscle activity to be greater
compared to that of alternating movements in the L-Dopa
ON state of PD patients (Marsden et al., 2001), whereas
other studies found this coherence suppressed (Hirschmann
et al., 2013) or restored by L-Dopa during movement (Salenius
et al., 2002). With a latency of 2 s from movement onset,
STN-motor cortex beta band coherence increased compared to
baseline, which was independent of dopaminergic medication
state (Litvak et al., 2012). In contrast, STN spectral power
and STN-motor cortex coherence in the beta band decreased
compared to baseline prior to and during movement in
unmedicated PD patients (Talakoub et al., 2016). Only these
two studies have explicitly looked at dynamic changes of STN
oscillatory activity and STN-cortex coherence to be dependent
on movement activity. This is of considerable significance
given that increased beta oscillations in motor cortex and basal
ganglia have been associated with immutability and steady state
in motor activity while being modulated during movement
change (Brittain and Brown, 2014) Additionally, the analysis
of dynamic changes in oscillatory beta band activity and
coherence between relay structures of the motor circuit may
be relevant in the process of defining physiological read-out
parameters for on demand stimulation systems as closed
loop techniques.
In the above-mentioned studies, recordings in the STN
were performed through externalized leads in the immediate
post-operative period, when a surgical stun effect may mitigate
the Parkinsonian OFF-state. Here, we investigated patients
implanted with the ACTIVA PC+Sr (Medtronic Inc.,
Minneapolis, MN, USA), a DBS device that is capable of
recording LFP activity from chronically implanted STN leads,
and studied the effect of motor task and dopaminergic state
on the modulation of beta band activity using an event-related
approach in PD patients. We were interested to test whether
the STN differentially encodes movements that involve changes
(here the voluntary alternating movement) and movements
that do not involve changes (here the isometric contraction),
and if so, where in time-frequency this differential processing
is localized.
PATIENTS AND METHODS
Patient Characteristics and DBS Device
The study protocol was approved by the ethical review
board of the University Hospital Würzburg and patients
provided written informed consent to participate prior to
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implantation. We investigated eight PD patients with the
following characteristics: mean age 58 years (range: 50–66),
one female, one left-handed, mean disease duration 13 years
(range: 10–19), mean pre-operative/post-operative L-Dopa-
equivalent-dose: 1295 mg/505 mg (range: 650–2725/180–800),
mean UPDRS III pre-operative L-Dopa OFF/pre-operative
L-Dopa ON/post-operative L-Dopa OFF stimulation ON: 49
(range: 40–69)/15 (range: 4–24)/14 (range: 9–19). Patients were
selected for STN-DBS according to established clinical criteria
and implanted with a CE-approved DBS device (ACTIVA
PC+Sr Medtronic Inc., Minneapolis, MN, USA), which has
the capability of recording LFP via standard, quadrupolar DBS
electrodes (3389, Medtronic Inc., Minneapolis, MN, USA). Data
can be stored within the device and downloaded later for off-line
analysis. The implantation of the DBS system was performed
according to standard clinical routine as described previously
(Steigerwald et al., 2008; Reese et al., 2012).
Experimental Procedure
The study was performed 3.5 ± 0.2 months after DBS
implantation when stimulation parameters and dopaminergic
medication had been optimized and a stable improvement of
PD motor symptoms had been achieved. Long-acting dopamine
agonists were suspended for about 3 days and L-Dopa was
withdrawn overnight at least 12 h before recording the dopamine
depleted state (L-Dopa OFF), while the L-Dopa-medicated state
(L-Dopa ON) was recorded 1 h after intake of 200 mg of soluble
L-Dopa/benserazide (Madopar LTr, Hoffmann-La Roche AG,
Switzerland). Patients were required to fast prior to medication.
Recordings were performed subsequently on the same day
in L-Dopa OFF and ON condition and STN-DBS remained
switched off during all experimental procedures.
Only the brain hemisphere with themost prominent STN beta
band activity in the L-Dopa OFF resting state (right n = 4, left
n = 4) and the contralateral bodyside was evaluated.
Patients were comfortably seated and asked to position the
evaluated forearm onto a table in front of them, while the
contralateral arm rested in their lap.
STN-LFP were recorded (sampling rate: 794 Hz, gain:
1,000 ×) from two adjacent electrode contacts with most
prominent beta activity and which were clinically effective. These
contacts were located at the dorsolateral STN as determined by an
image fusion of the pre-operative magnetic resonance imaging
(MRI)- and post-operative CT-scan (Optiviser Software,
Medtronic Inc., Minneapolis, MN, USA). Electromyogram
(EMG; sampling rate: 1 kHz, 7–500 Hz anti-aliasing band-pass
filter) was recorded via two adhesive surface electrodes
(1 cm diameter, Ag/AgCl, Zebris Medical GmbH, Germany)
positioned on the wrist extensor muscles. For subsequent
alignment of EMG and LFP recordings, a brief high-frequency
electrical train pulse was applied via a standard TENS device
(transcutaneous electrical nerve stimulation) at the start and end
of each recording, creating a stimulus artifact in the LFP and
EMG recordings.
Two simple motor tasks were performed in random order,
each three times for at least 30 s: submaximal tonic = isometric
wrist extension (ISO) or self-paced, alternating wrist flexion and
extension (ALT).
Signal Analysis
Preprocessing
STN-LFP and EMG recordings were inspected offline for
artifacts using Spike2 software (CED, Cambridge, UK). EMG
signals were downsampled to 794 Hz and aligned with STN-LFP
recordings based on the sharp onset of the TENS artifact. Data
were then further processed in MATLAB (Release 2016b, The
MathWorks, Inc., Natick, MA, USA). Movement onset and
stop was detected by a threshold method on the z-transformed
envelope of the band-pass filtered EMG (Butterworth filter
of 4th order with cut-off frequencies 110 Hz and 140 Hz)
and visually confirmed. STN-LFP and EMG recordings were
band-pass filtered between 1 Hz and 90 Hz using an IIR
Butterworth filter of 4th order using a forward and a reverse pass.
Both recording types were then baseline-corrected via simple
subtraction of mean voltage between −4 s and −2 s relative to
movement onset. Epochs of±5 s duration were extracted relative
to movement onset.
Long-Range Coupling and STN Spectral Power
STN-muscular functional connectivity was evaluated by means
of wavelet coherence, which is a measure of amplitude and
of the consistency of phase relationships between STN-LFP vs.
EMG across time (Grinsted et al., 2014). EMG was not rectified
since rectification leads to inconsistencies in the extraction of
oscillatory content in muscle activity in the presence of varying
levels of contraction (Farina et al., 2013; McClelland et al., 2014).
EMGs were not baseline-corrected in the frequency domain.
The fact that statistical properties of the EMG are expected
to vary across time during changes in muscular activity does
not pose a problem when using wavelet coherence (as opposed
to Fourier coherence) since wavelet methodology does not
presuppose the underlying signals to be stationary (Zhan et al.,
2006). Coherence values were obtained using Morlet wavelets
by means of MATLAB’s wavelet coherence function (with
ω0 = 6) as a trade-off between time and frequency localization
(van Vugt et al., 2007). Wavelet coherence values were trial-
averaged for each subject and condition (ALT OFF, ALT ON,
ISO OFF, ISO ON).
STN-LFP power spectral density values were computed
via Fieldtrip’s ft_frequency analysis function using Hanning
windows as tapers before performing a Fourier transformation
(Oostenveld et al., 2011). In order to perform both regions
of interest (ROI)-based analysis of variance and permutation
tests comparing the pre-movement baseline to movement, power
values were computed for frequencies 4–50 Hz with a resolution
of 1 Hz, with time window length of 500 ms and a step size of
50 ms. Recordings were analyzed from −5 s to 5 s relative to
movement onset.
Statistics
An unbiased, data-driven ROI was identified as the largest region
of coherence within the confines of 0–1 s and 1–50 Hz on
the mean coherogram across subjects of the mean coherogram
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across the four conditions. ROIs were selected by drawing a
quadrilateral over the prominent regions of coherence visible
on the grand average map after masking away coefficients
under 0.3. Examining the average across conditions precludes
double dipping (Kriegeskorte et al., 2009). Mean coherence
values within the identified ROI were subsequently extracted
for each patient and condition. The effects of dopamine and
movement type on STN-EMG coherence were analyzed using a
two-way analysis of variance (ANOVA) with repeated measures
for both fixed effects, namely DOPAMINE (with levels OFF
and ON) and MOVEMENT (with levels ALT and ISO) that
included SUBJECTS as a random effect. In order to examine
whether dopamine and movement type effect on STN-EMG
coherence by parallel, frequency-specific modulation of STN
spectral power and EMG activity, the same ROI was employed
on trial-averaged power spectral density data and analyzed
using the same factorial design as above. For this, trial-averages
were baseline-corrected by computing the decibel changes from
baseline (−4 to −2 s relative to movement onset). Statistical
significance was set at p = 0.05/(number of ROIs) to correct for
multiple comparisons.
In addition, movement-induced changes in STN spectral
power were compared to baseline levels via nonparametric
permutation testing (Theiler et al., 1992; Maris and Oostenveld,
2007; MATLAB code adapted from Cohen, 2014). The goal
was to create a null hypothesis distribution to compare our
observed data to. Here, the null hypothesis states that movement
initiation induces no difference in STN spectral power with
respect to baseline, and therefore any temporal reordering of
the data should possess statistical properties similar to those
of the observed dataset. Prior to permutation, power maps
were smoothed with a 2-D Gaussian kernel (σ = 2). The
baseline vs. movement comparison was conducted for each
condition separately, as well as after averaging across conditions
for each subject. First, an average map across subjects (the
‘‘observed map’’) was computed and was baseline-corrected by
obtaining the decibel change from its baseline. Each permutation
was obtained by randomly selecting a timepoint t within the
epoch, then dividing each (uncorrected) subject map at t into
two submaps and placing the earlier submap after the later
submap, thus essentially randomly shifting the subject maps
along the time axis. Time-shifted subject maps were then
averaged and subsequently baseline-corrected by computing
the decibel change from the baseline values of the observed
map. This process was repeated 1,000 times to have a null
hypothesis distribution of power values for each time-frequency
bin. To determine statistical significance, a z-map was computed
by bin-wise subtracting the mean of the distribution from
the observed map and dividing by the standard deviation of
the distribution. The z-map was thresholded such that only
z-scores corresponding to a p-value of 0.01 or less survived.
The p-value threshold was chosen to account for multiple
comparisons (here 4). The ensuing clusters of significant
points were corrected by eliminating clusters with pixel sizes
lower than a cluster size threshold defined by the permuted
data. To derive such threshold, a distribution of maximum
cluster sizes was obtained as follows. Each permutation was
standardized by subtracting the mean permutation map and
dividing by its standard deviation, yielding z-maps which were
thresholded as above, after which the maximum cluster size
was stored. The cluster size threshold was defined as equal
or greater than the 99th percentile of the distribution of
largest clusters.
RESULTS
3.5 months after implantation all patients presented an excellent
response to STN-DBS reaching at least 80% of the pre-operative
UPDRS-III L-Dopa-ON score. One patient (ID 4) was excluded
from the analysis since she/he could not complete the whole
experiment due to severe OFF motor symptoms. Two trials
from subject-ID 3 were rejected after visual inspection due to
electrical artifacts. Total number of ISO trials were n = 21 for
L-Dopa-OFF and n = 20 for L-Dopa-ON. For ALT trials
n = 20 for L-Dopa-OFF and n = 21 for L-Dopa-ON. Exemplary
raw STN-LFP and EMG epochs and corresponding spectrograms
can be seen in Figure 1.
STN-Muscular Coherence
Two prominent regions of STN-EMG coherence were identified,
namely ‘‘high beta 1’’ in the frequency range 28–44 Hz
soon after movement onset (50–150 ms) and ‘‘high beta 2’’
enclosed by the ranges 23–37 Hz and 300–500 ms (Figure 2).
Shapiro-Wilk tests on each model’s residuals yielded W = 0.96,
p = 0.37 and W = 0.95, p = 0.19, respectively. The results of
the repeated-measures ANOVAs can be seen in Table 1. We
conducted a two-way repeated-measures ANOVA to compare
the effect of dopamine and movement type on STN-EMG
coherence. Coherence in high beta 1 showed a DOPAMINE
trend (F(1,6) = 5.4, p = 0.059) and no significant MOVEMENT or
interaction effects. In contrast, high beta 2 yielded a significant
FIGURE 1 | Raw recordings and spectrograms. Example raw subthalamic
nucleus (STN)-Local Field Potentials (LFPs) and electromyogram (EMG)
epochs from subject wue11 during an isometric contraction in medication
state ON. The corresponding spectrograms display the trial-average power
spectral densities for the same subject and condition for the STN-LFP and
the EMG, respectively. The spectrograms show the decibel change from
baseline (−4 s to −2 s relative to movement onset).
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TABLE 1 | Summary of statistics of subthalamic nucleus (STN) and electromyogram (EMG) coherence and STN power.
STN-EMG Coherence STN Power (dB)
High β1 High β2 High β1 High β2
Dopamine
OFF 0.29 ± 0.01 0.33 ± 0.02 −1.4 ± 0.36 −2.02 ± 0.53
ON 0.36 ± 0.02 0.34 ± 0.02 −0.09 ± 0.43 −0.69 ± 0.48
F(1,6) = 5.41 F(1,6) = 0.12 F(1,6) = 3.65 F(1,6) = 2.27
p = 0.059 p = 0.75 p = 0.10 p = 0.18
η2p = 0.47 η
2
p = 0.02 η
2
p = 0.38 η
2
p = 0.27
Movement type
ALT 0.33 ± 0.02 0.34 ± 0.02 −0.29 ± 0.42 −1.13 ± 0.58
ISO 0.32 ± 0.01 0.34 ± 0.02 −1.2 ± 0.42 −1.58 ± 0.48
F(1,6) = 0.26 F(1,6) = 0.005 F(1,6) = 6.73 F(1,6) = 2.61
p = 0.63 p = 0.95 p = 0.041 p = 0.16
η2p = 0.04 η
2
p < 0.01 η
2
p = 0.53 η
2
p = 0.30
Dopamine × Movement type
OFF ALT 0.29 ± 0.02 0.35 ± 0.03 −1.2 ± 0.43 −2.1 ± 0.88
ON ALT 0.37 ± 0.04 0.32 ± 0.03 0.59 ± 0.56 −1.15 ± 0.61
OFF ISO 0.30 ± 0.02 0.31 ± 0.02 −1.6 ± 0.61 −1.93 ± 0.67
ON ISO 0.34 ± 0.01 0.36 ± 0.03 −0.78 ± 0.58 −1.23 ± −73
F(1,6) = 1.08 F(1,6) = 9.37 F(1,6) = 0.51 F(1,6) = 1.32
p = 0.34 p = 0.02∗ p = 0.5 p = 0.3
η2p = 0.15 η
2
p = 0.61 η
2
p = 0.08 η
2
p = 0.18
Statistics. ROI values for STN-EMG coherence and baseline-corrected STN power shown as mean ± SEM, and statistics for each effect of the repeated measures ANOVAs. An
asterisk indicates statistical significance, which was set at p = 0.025 (p-values shown uncorrected).
DOPAMINE × MOVEMENT interaction (F(1,6) = 9.37,
p = 0.022; Figure 3), wherein the OFF state coherence is higher in
ALT (0.35 ± 0.03) than in ISO (0.31 ± 0.02), whereas in the ON
state functionally connectivity was stronger in ISO (0.36 ± 0.03)
than in ALT (0.32± 0.03). STN-EMGwavelet coherence was not
significantly modulated by dopamine or movement type.
STN Spectral Power
We analyzed the same ROIs with the power data using the
same design as above (Figure 4). For STN-LFPs, Shapiro-Wilk’s
tests on residuals yielded W = 0.97, p = 0.55 and W = 0.95
p-value = 0.23, respectively. However, no effects were significant
for both ROIs. For EMG synchronization, normality of the
residuals was violated for both ROIs (Shapiro-Wilk tests, where
high beta 1: W = 0.78, p = 5.645e-05; high beta 2: W = 0.87,
p = 0.0019). As expected, the permutation test for subject-
average maps showed a significant cluster of high beta (about
18–28 Hz) desynchronization starting just before movement
onset (about −50 ms to 1,000 ms; Figure 5). However, among
the different conditions, this pattern was only significant at the
onset of the alternating movement in the ON state (data not
shown). Interestingly, a pattern of high beta (about 23–33 Hz)
resynchronization is observable 1,000–3,500 ms after movement
onset in theON state for bothmovement types but not in theOFF
state. A two-way ANOVA designed as above threw no significant
effects (data not shown).
DISCUSSION
We assessed the STN-LFP spectral power and STN-LFP-EMG
coherence of two different movement patterns after movement
onset, namely ISO and alternating wrist flexion and extension,
as well as the effect of L-Dopa medication in PD patients. Our
finding of movement-related beta desynchronization within the
STN is not surprising and is in agreement with numerous studies
describing beta oscillations as corresponding to antikinetic
activity (Cassidy et al., 2002; Levy et al., 2002; Priori et al., 2002;
Kühn et al., 2004; Alegre et al., 2005, 2013; Doyle et al., 2005;
Foffani et al., 2005; Hebb et al., 2012; Joundi et al., 2012, 2013;
Litvak et al., 2012). Using an unbiased, data-driven approach,
we identified two ROIs in the upper beta band within the first
second after movement onset (Figure 2). At 300–500 ms, we
found a significant DOPAMINE × MOVEMENT interaction
for coherent activity, with greater upper beta band coherence
in the isometric contraction task compared to alternating wrist
movements in the L-Dopa medicated state. This pattern might
go awry in the unmedicated state, where coherence is higher for
alternating wrist movements. As the peak amplitude of EMG
activity occurred at 555 ms after movement onset, i.e., about
50 ms after our defined ROI ends, the prominent STN-EMG
coherence cannot be solely traced back to the peak EMG
amplitude. The identified ROIs turned out to be after movement
onset, where the realized movement is identical between ISO
and ALT. In the STN, activity at this short period may still
be differently encoded if the STN also encodes whether the
movement itself involves change or not. That is, ALT and ISO can
be considered (1) each a unit of ongoing contractions which are
different from rest (hence beta desynchronization at movement
onset), or (2) they can, in addition, be encoded as a series of
subunits if the movement itself involved different phases (as
is the case in ALT). If (2) is true, then the STN activity may
represent ALT and ISO differently via differential spectral power
profiles. However, because the identified ROIs do take place after
movement onset, one could argue that the prominent regions
of STN-EMG coherence could reflect basal ganglia movement
control (Graybiel et al., 1994; Yin, 2014).
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FIGURE 2 | Regions of interest (ROIs) extraction. Two ROIs were extracted
from the grand average map of STN-EMG coherence. The map displays the
average coherence across all conditions within the ranges 0–1 s and
4–50 Hz. Two sizeable ROIs were identified: “high beta 1” within 28–44 Hz
and 50–150 ms and “high beta 2” enclosed by the ranges 23–37 Hz and
300–500 ms.
FIGURE 3 | Coherence statistics. (A,B) Stronger high beta coherence soon
after movement onset (50–150 ms) was observed in the medication ON state,
though this was only marginally significant (F(1,6) = 5.41, uncorrected
p = 0.059, η2p = 0.47). (C,D) A significant dopamine × movement type effect
(F(1,6) = 9.37, uncorrected p = 0.02, η2p = 0.61) on high beta coherence was
observed later between 300 and 500 ms after movement onset.
Methodological Considerations and
Possible Confounders
The recordings were obtained several weeks after implantation
of the electrodes and therefore rapid impedance changes are
FIGURE 4 | Spectrograms across conditions. Average spectrograms across
subjects depicting first second after movement onset for each condition with
ROIs. Hard line and dashed line correspond to high beta 1 and 2,
correspondingly.
unlikely and should not have affected data quality (Rosa et al.,
2010). The micro-lesioning effect due to insertion of the
electrodes into the STN, which often attenuates Parkinsonian
motor symptoms and naturally interferes with stimulation and
medication effects, had abated at the time of the experiment
as evidenced by patients reaching their pre-operative symptom
severity after withdrawal of medication and DBS. We recorded
LFPs in a bipolar montage from adjacent contacts with most
prominent beta activity during a resting state in L-Dopa-
OFF, which may indicate the motor part of the STN (Yoshida
et al., 2010; Accolla et al., 2016; Horn et al., 2017). These
contacts were located at the dorsolateral aspect of the STN
according to an image fusion of the pre-operative MRI and
the post-operative CT-scan (Optiviser software, Medtronic Inc.,
Minneapolis, MN, USA) and were of good clinical efficacy
of STN-DBS. Nevertheless, this is a pragmatic and mostly
electrophysiologically-driven delineation of the STN motor
region, which may not correspond to the ‘‘true’’ physiological
motor area in individual patients. Likewise, the low number of
patients and trials may have led to reduced sensitivity, however,
we draw this sample given by the restricted availability of the
PC + S stimulation systems.
Subthalamic Nucleus-Muscle Coherence
(STN-Muscle Coupling)
Within the two identified ROIs a trend of the dopamine effect
was observed for the first ROI (50–150ms) with higher coherence
in medicated patients (Figures 2, 3). Concerning the second
ROI (300–500 ms), an interaction effect of L-Dopa medication
and movement task was significant with higher coherence
in the isometric contraction task compared to alternating
movements, an effect which was reversed in the dopaminergic
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FIGURE 5 | Movement-induced high beta desynchronization.
(A) Baseline-corrected grand average map, where each subject map was the
average across all four conditions. (B) After cluster correction, a final cluster
survives showing event-related desynchronization and located at about
−50 to 1,000 ms and 18–27 Hz.
OFF state. Owing to the fact that EMG recordings reflect lower
motor neuron synchronization only after movement start, we
cannot compare our data to the pre-movement period. In a
study employing a comparable movement task, the coherence
magnitude between the motor cortex and the STN in the
upper beta band was markedly attenuated during movement
(Talakoub et al., 2016).
Movement-Related STN Spectral Power
The previously mentioned increase in beta desynchronization
in the L-Dopa ON state compared to the OFF state (Doyle
et al., 2005; Devos et al., 2006; Androulidakis et al., 2007) did
not reach a level of significance in our study, which could
be attributed to a low signal-to-noise ratio and sample size.
Likewise, no significant influence of the movement task could
be detected. Joundi et al. (2013) could show that a finger
tapping induced suppression of STN spectral power may be
independent of the velocity of these repetitive movements
and an inter-movement rebound of beta synchronization may
only be suppressed at higher tapping rates. The degree of
desynchronization has moreover been shown to depend on
the effort of the respective motor task, which may reach a
floor effect at higher efforts. The latter strongly correlated with
spectral power in the gamma band (55–90 Hz; Tan et al., 2013,
2015). Attenuated cortical post-movement beta synchronization
has been shown in bradykinetic-rigid PD compared to healthy
controls (Pfurtscheller et al., 1998; Tamás et al., 2003). In our
data, high beta (about 23–33 Hz) resynchronization in the STN
about 1,000–3,500 ms after movement onset was stronger in the
ON than in the OFF medication state, although not significantly
so (Figure 4).
Physiological Considerations
Synchronized oscillatory activity between remote neuronal
populations can facilitate information processing over large
distances (Varela et al., 2001; Schnitzler and Gross, 2005).
There is good evidence that motor system communication over
large distances is physiologically realized via the segregation
of synchronization in distinct frequency bands. In this view,
motor cortical synchronization in the beta band was initially
regarded as representing ‘‘idleness’’ (Pfurtscheller et al., 1996)
but it may instead be conductive to motor constancy (Brittain
and Brown, 2014). For instance, studies have shown that
movement onset is accompanied by desynchronization of
motor cortical beta activity (event-related desynchronization,
ERD) with rebound synchronization around movement stop
(Pfurtscheller and Lopes da Silva, 1999). In PD patients,
the motor cortical pre-movement ERD is delayed and its
hemispheric specificity is reduced compared to healthy controls
(Defebvre et al., 1993, 1994, 1996; Magnani et al., 1998).
Exaggerated beta synchrony is therefore strongly associated with
the OFF (dopamine depleted)motor state (Jenkinson and Brown,
2011). Conversely, post-movement beta synchronization (PMBS)
is attenuated in PD (Pfurtscheller et al., 1998; Tamás et al.,
2003), which may be a marker of certainty in feedforward
control ofmovements. In healthy subjects, PMBS has been shown
to be negatively correlated with uncertainty in feedforward
estimations (Tan et al., 2016).
We used PD as a model disease to further investigate the
role of dopamine in the context of motor activity and we
reproduced a movement-dependent ERD of STN beta activity
(Cassidy et al., 2002; Levy et al., 2002; Priori et al., 2002;
Kühn et al., 2004; Alegre et al., 2005, 2013; Doyle et al., 2005;
Foffani et al., 2005; Hebb et al., 2012; Joundi et al., 2012,
2013; Litvak et al., 2012), whose magnitude, however, was
not significantly affected by dopamine substitution. Long-range
STN-muscle coherence in the upper beta band increased shortly
after movement onset and a trend of a dopamine effect
could be observed with stronger functional connectivity in
the ON state. Thus, beta spectral power per se might not
simply be a universal marker of bradykinesia. Instead, our
data suggest STN beta spectral power to be present at motor
rest and reduced with changes in motor activity (ERD) while
a subset of neurons, however, functionally connects to the
spinal motor neuron pool (measured by EMG activity). Only
after substitution of L-Dopa was STN-muscle coherence in the
upper beta band stronger in the isometric contraction task
compared to alternating movements. Assuming that this state
is closer to normal motor function than in PD patients off
L-Dopa medication, beta coherence could physiologically limit
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the amount of information conveyed between remote structures,
which may be necessary to maintain simple movements like
the isometric contraction. In this view, a physiologically inverse
relationship between neuronal synchrony and information flow
has been hypothesized (Hanslmayr et al., 2012; Oswal et al.,
2013). Our data also suggest that higher striatal dopamine levels
may be essential for an appropriate setting of neuronal synchrony
in the STN and information flow between remote structures of
the motor circuit. Salenius et al. (2002) reported a similar effect
of L-Dopa with restorage of cortico-muscular beta coherence
in PD patients during the isometric contraction of contralateral
forearm muscles.
Muscle activity synchronized in higher frequencies of
about 40 Hz (called Piper-rhythm, see Piper, 1912) can be
recorded from muscles of normal subjects during muscle
activity near maximum contraction force (McAuley et al.,
1997). In PD patients, impaired muscle strength in the
medication OFF state (Yanagawa et al., 1990; Corcos et al.,
1996) is correlated with a disruption of this higher frequency
synchronization patterns, both of which return to normal levels
in patients after L-Dopa substitution (McAuley et al., 2001).
Accordingly, the basal ganglia-lower motor neuron coupling
detected in our study may be a physiological phenomenon
necessary for normal motor execution. Consequently,
impaired coupling on various relay stations of the motor
circuit in PD may contribute to Parkinsonian OFF motor
symptoms, such as bradykinesia, hypokinesia and reduced
muscle strength.
A simple monosynaptic connection between basal ganglia
nuclei and spinal motor neurons is unknown (Lanciego et al.,
2012), thus anatomical pathways explaining our findings have
to be discussed. Motor cortical beta oscillatory activity has been
shown to drive beta oscillations in the STN (Williams et al., 2002;
Fogelson et al., 2006; Litvak et al., 2011), most likely via the
so-called ‘‘hyperdirect pathway’’ (HDP; Monakow et al., 1978;
Nambu et al., 1996, 1997). Recently, the HDP has also been
uncovered and further characterized in humans (Brunenberg
et al., 2012; Miocinovic et al., 2018). This pathway may represent
the anatomical correlate of clinical efficacy of STN-DBS which
may act via a retrograde propagation of DBS signals to the motor
cortex (Gradinaru et al., 2009; Li et al., 2012; de Hemptinne
et al., 2015; Sanders and Jaeger, 2016). Accordingly, a certain
anatomical proximity of the DBS electrode may be necessary for
good clinical efficacy of STN-DBS in PD (Akram et al., 2017;
Horn et al., 2017; Chen et al., 2018). It remains to be further
investigated whether the activity in the upper beta band we
recorded from STN and which was coherent to the EMG may
mirror motor cortical activity. This hypothesis is corroborated
by resting state data showing STN-motor cortical coherence
in the upper beta band, whereas STN spectral power was
prominent in the lower beta band in patients withdrawn from
medication (Litvak et al., 2011).
Our study adds dynamic properties to the complex interplay
between STN beta spectral power and its coherence with remote
structures of the motor system as a function of movement
and dopaminergic state. This may help to identify markers of
neuronal activity relevant for more individualized paradigms of
DBS therapy.
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